Secretariat and FAPA Office Reform
July 31, 2016
Separation of Dispensing and Prescribing Practices (SDP)
February 25, 2017

Non-Communicable Disease (NCD)

Combating Chronic Non-Communicable Diseases (NCDs)

On 10 November 2016, FAPA officially announced its statement regarding NCDs during the opening ceremonies of the 26th FAPA Congress. This was drafted from a stakeholders’ forum and workshop conducted during the pre-congress session held on 9 November 2016 at the Bangkok International Trade and Exhibits Center (BITEC) in Bangkok, Thailand. The goal of the forum and workshop was to come up with cost-effective programs in health promotion, risk assessment, and interventions and to pledge their support to contribute significantly to the attainment of the global goals on non-communicable diseases.

2016 FAPA Statement on NCDs

FAPA recognizes the multiple and negative health and socio-economic impact of noncommunicable diseases in the Asian population. It acknowledges that conditions such as high blood pressure, obesity, high blood glucose and
hyperlipidemia are consequences of unhealthy diets, sedentary lifestyle, exposure to or use of tobacco, and alcohol intake, amongst a myriad of behavioral risk factors which are preventable and controllable. In addition, inequality in the access to, and responsible and rational use of medicines for NCDs must be given due attention to halt the progression of these diseases among diagnosed patients. Through a comprehensive and multidisciplinary approach,
reduction of risk factors and proper management of these diseases could be achieved. The pharmacist is trusted and viewed by FAPA as one important health professional who could make substantial contribution to the prevention and control of NCDs such as hypertension and diabetes. The pharmacists’ training and expertise together with their
strategic practice settings in the community, government and private health institutions, research and academic institutions, and health policy-makingbodies in Asia, are positioned to create, initiate, sustain, and be actively involved in programs and activities on health promotion, risk assessment, and treatment adherence in their respective countries together with all health professionals, patients, administrators, government agencies, and other stakeholders. As a federation of pharmaceutical associations in Asia with a mission of improving lives of people through good pharmacy practice, FAPA believes that its member associations can support the nine (9) global strategies advocated by the WHO which are:

1. A 25% relative reduction in the overall
mortality from cardiovascular diseases, cancer,
diabetes, or chronic respiratory diseases;
2. At least 10% relative reduction in the harmful
use of alcohol, as appropriate, within the
national context;
3. A 10% relative reduction in prevalence of
insufficient physical activity;
4. A 30% relative reduction in mean population
intake of salt/sodium;
5. A 30% relative reduction in prevalence of
current tobacco use;
6. A 25% relative reduction in the prevalence of
raised blood pressure or contain the
prevalence of raised blood pressure, according
to national circumstances;
7. Halt the rise in diabetes and obesity;
8. At least 50% of eligible people receive drug
therapy and counselling (including glycemic
control) to prevent heart attacks and strokes;
9. An 80% availability of the affordable basic
technologies and essential medicines,
including generics, required to treat major noncommunicable
diseases in both public and
private facilities.

To achieve the above goals, FAPA through its member associations, had defined nine (9) possible interventions by which Asian pharmacists can provide pharmaceutical care and encourage healthy lifestyle, namely:
1. Wellness promotion and healthy lifestyle
2. Smoking cessation programs
3. Public awareness campaigns on the health
effects of alcohol and smoking
4. Nutrition education
5. Physical fitness programs
6. Risk screening programs for hypertension and
diabetes and other NCDs
7. Programs on responsible and rational use of
medicines for various NCDs with focus on
hypertension and diabetes
8. Promotion of treatment adherence through
patient-centered counselling
9. Active participation in multidisciplinary and
government-initiated programs on NCDs
including access to medicines

FAPA takes the responsibility of encouraging the adoption of the abovementioned programs and in gathering all evidences of the positive health and socioeconomic outcomes of the different approaches adopted by member associations. It will constantly provide a venue for country member associations to exchange expertise and experiences on NCD prevention and management and recognize resulting practice models which countries in the Region may adopt and implement. FAPA should also assist member associations in designing and implementing programs on: building capacity of pharmacy human resource; improving relationship with other healthcare professionals, clients and public; increasing influence in public health policy making; and, in ensuring sustainable
financing for NCD-related pharmacy initiatives and services. Lastly, FAPA will continuously work with various
stakeholders to contribute significantly to the attainment of the global goals on non-communicable diseases. Together, as one family with a common mission, FAPA envisions better health for all Asians.